BCR/ABL stimulates WRN to promote survival and genomic instability

Cancer Research

Volumn 71, Issue 3, 2011, Pages 842-851

  Slupianek, Artur ^a   Poplawski, Tomasz ^c   Jozwiakowski, Stanislaw K ^b   Cramer, Kimberly ^a   Pytel, Dariusz ^a   Stoczynska, Ewelina ^c   Nowicki, Michal O ^b   Blasiak, Janusz ^c   Skorski, Tomasz ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Temple University   (United States)

^c UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CASPASE; DNA BASE; EXONUCLEASE; HELICASE; MESSENGER RNA; MYC PROTEIN; PROTEIN BCL XL; WERNER SYNDROME PROTEIN;

APOPTOSIS; ARTICLE; CELL PROTECTION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; GENOMIC INSTABILITY; GENOTOXICITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION;

ANIMALS; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; DISEASE PROGRESSION; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; DNA, NEOPLASM; EXODEOXYRIBONUCLEASES; FUSION PROTEINS, BCR-ABL; GENOMIC INSTABILITY; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MICE; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECOMBINANT FUSION PROTEINS; RECQ HELICASES;

EID: 79551530347     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-1066     Document Type: Article

References (50)

1. Turner SD, Alexander DR. Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells. Leukemia 2006;20:572-82.
2. Marley SB, Gordon MY. Chronic myeloid leukaemia: stem cell derived but progenitor cell driven. Clin Sci (Lond) 2005;109:13-25.
3. Perrotti D, Jamieson C, Goldman J, Skorski T. Chronic myeloid leukemia: mechanisms of blastic transformation. J Clin Invest 2010;120:2254-64.
4. Koptyra M, Falinski R, Nowicki MO, Stoklosa T, Majsterek I, Nieborowska- Skorska M, et al. BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance. Blood 2006;108:319-27. [Epub 2006 Mar 9].
5. Slupianek A, Hoser G, Majsterek I, Bronisz A, Malecki M, Blasiak J, et al. Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)/M phase, and protection from apoptosis. Mol Cell Biol 2002;22:4189-201.
6. Nowicki MO, Falinski R, Koptyra M, Slupianek A, Stoklosa T, Gloc E, et al. BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks. Blood 2004;104:3746-53. [Epub 2004 Aug 10]. (Pubitemid 39564453)
7. Cramer K, Nieborowska-Skorska M, Koptyra M, Slupianek A, Penserga ET, Eaves CJ, et al. BCR/ABL and other kinases from chronic myeloproliferative disorders stimulate single-strand annealing, an unfaithful DNA double-strand break repair. Cancer Res 2008;68:6884-8.
8. Gaymes TJ, Mufti GJ, Rassool FV. Myeloid leukemias have increased activity of the nonhomologous end-joining pathway and concomitant DNA misrepair that is dependent on the Ku70/86 heterodimer. Cancer Res 2002;62:2791-7.
9. Fernandes MS, Reddy MM, Gonneville JR, DeRoo SC, Podar K, Griffin JD, et al. BCR-ABL promotes the frequency of mutagenic single-strand annealing DNA repair. Blood 2009;114:1813-9. [Epub 2009 Jul 1].
10. Bohr VA. Rising from the RecQ-age: the role of human RecQ helicases in genome maintenance. Trends Biochem Sci 2008;33:609-20.
11. Opresko PL, Calvo JP, von Kobbe C. Role for the Werner syndrome protein in the promotion of tumor cell growth. Mech Ageing Dev 2007;128:423-36.
12. Futami K, Ishikawa Y, Goto M, Furuichi Y, Sugimoto M. Role of Werner syndrome gene product helicase in carcinogenesis and in resistance to genotoxins by cancer cells. Cancer Sci 2008;99:843-8. [Epub 2008 Feb 26].
13. Shiratori M, Sakamoto S, Suzuki N, Tokutake Y, Kawabe Y, Enomoto T, et al. Detection by epitope-defined monoclonal antibodies of Werner DNA helicases in the nucleoplasm and their upregulation by cell transformation and immortalization. J Cell Biol 1999;144:1-9.
14. Grandori C, Robinson KL, Galloway DA, Swisshelm K. Functional link between Myc and the Werner gene in tumorigenesis. Cell Cycle 2004;3:22-5. (Pubitemid 40268579)
15. Nieborowska-Skorska M, Hoser G, Kossev P, Wasik MA, Skorski T. Complementary functions of the antiapoptotic protein A1 and serine/ threonine kinase pim-1 in the BCR/ABL-mediated leukemogenesis. Blood 2002;99:4531-9.
16. Slupianek A, Schmutte C, Tombline G, Nieborowska-Skorska M, Hoser G, Nowicki MO, et al. BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance. Mol Cell 2001;8:795-806.
17. Nowicki MO, Pawlowski P, Fischer T, Hess G, Pawlowski T, Skorski T. Chronic myelogenous leukemia molecular signature. Oncogene 2003;22:3952-63.
18. Grandori C, Wu KJ, Fernandez P, Ngouenet C, Grim J, Clurman BE, et al. Werner syndrome protein limits MYC-induced cellular senescence. Genes Dev 2003;17:1569-74.
19. Wu A, Sciacca L, Baserga R. Nuclear translocation of insulin receptor substrate-1 by the insulin receptor in mouse embryo fibroblasts. J Cell Physiol 2003;195:453-60. (Pubitemid 36529873)
20. Bennett PA, Dixon RJ, Kellie S. The phosphotyrosine phosphatase inhibitor vanadyl hydroperoxide induces morphological alterations, cytoskeletal rearrangements and increased adhesiveness in rat neutrophil leucocytes. J Cell Sci 1993;106:891-901.
21. Slupianek A, Gurdek E, Koptyra M, Nowicki MO, Siddiqui KM, Groden J, et al. BLM helicase is activated in BCR/ABL leukemia cells to modulate responses to cisplatin. Oncogene 2005;24:3914-22.
22. Cheng WH, von Kobbe C, Opresko PL, Fields KM, Ren J, Kufe D, et al. Werner syndrome protein phosphorylation by abl tyrosine kinase regulates its activity and distribution. Mol Cell Biol 2003;23:6385-95.
23. Slupianek A, Nowicki MO, Koptyra M, Skorski T. BCR/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cells. DNA Repair (Amst) 2006;5:243-50. [Epub 2005 Nov 16].
24. Cho RL, Johnson DE. Characterization of caspase proteases in cytokine-dependent myeloid progenitor cells using enzyme affinity labeling. J Cell Biochem 1999;73:79-89.
25. Lieber MR. The mechanism of human nonhomologous DNA end joining. J Biol Chem 2008;283:1-5. [Epub 2007 Nov 12].
26. Nieborowska-Skorska M, Stoklosa T, Datta M, Czechowska A, Rink L, Slupianek A, et al. ATR-Chk1 axis protects BCR/ABL leukemia cells from the lethal effect of DNA double-strand breaks. Cell Cycle 2006;5:9.
27. Rink L, Slupianek A, Stoklosa T, Nieborowska-Skorska M, Urbanska K, Seferynska I, et al. Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells. Blood 2007;110:651-60. [Epub 2007 Apr 12].
28. Zhuang J, Jiang G, Willers H, Xia F. Exonuclease function of human Mre11 promotes deletional nonhomologous end joining. J Biol Chem 2009;284:30565-73.
29. Turaga RV, Paquet ER, Sild M, Vignard J, Garand C, Johnson FB, et al. The Werner syndrome protein affects the expression of genes involved in adipogenesis and inflammation in addition to cell cycle and DNA damage responses. Cell Cycle 2009;8:2080-92.
30. Chen L, Huang S, Lee L, Davalos A, Schiestl RH, Campisi J, et al. WRN, the protein deficient in Werner syndrome, plays a critical structural role in optimizing DNA repair. Aging Cell 2003;2:191-9.
31. Bischof O, Galande S, Farzaneh F, Kohwi-Shigematsu T, Campisi J. Selective cleavage of BLM, the bloom syndrome protein, during apoptotic cell death. J Biol Chem 2001;276:12068-75.
32. Amarante-Mendes GP, Naekyung Kim C, Liu L, Huang Y, Perkins CL, Green DR, et al. Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome c and activation of caspase-3. Blood 1998;91:1700-5.
33. Boulikas T. Nuclear import of DNA repair proteins. Anticancer Res 1997;17:843-63.
34. Vaitiekunaite R, Butkiewicz D, Krzesniak M, Przybylek M, Gryc A, Snietura M, et al. Expression and localization of Werner syndrome protein is modulated by SIRT1 and PML. Mech Ageing Dev 2007;128:650-61.
35. Agrelo R, Cheng WH, Setien F, Ropero S, Espada J, Fraga MF, et al. Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. Proc Natl Acad Sci U S A 2006;103:8822-7.
36. Brady N, Gaymes TJ, Cheung M, Mufti GJ, Rassool FV. Increased error-prone NHEJ activity in myeloid leukemias is associated with DNA damage at sites that recruit key nonhomologous end-joining proteins. Cancer Res 2003;63:1798-805.
37. Richardson C, Stark JM, Ommundsen M, Jasin M. Rad51 overexpression promotes alternative double-strand break repair pathways and genome instability. Oncogene 2004;23:546-53. (Pubitemid 38175009)
38. Elliott B, Richardson C, Jasin M. Chromosomal translocation mechanisms at intronic alu elements in mammalian cells. Mol Cell 2005;17:885-94.
39. Machwe A, Xiao L, Groden J, Matson SW, Orren DK. RecQ family members combine strand pairing and unwinding activities to catalyze strand exchange. J Biol Chem 2005;280:23397-407. [Epub 2005 Apr 20].
40. Baynton K, Otterlei M, Bjoras M, von Kobbe C, Bohr VA, Seeberg E. WRN interacts physically and functionally with the recombination mediator protein RAD52. J Biol Chem 2003;278:36476-86. [Epub 2003 May 15].
41. Jasin M. Chromosome breaks and genomic instability. Cancer Invest 2000;18:78-86.
42. Heidenreich E, Novotny R, Kneidinger B, Holzmann V, Wintersberger U. Non-homologous end joining as an important mutagenic process in cell cycle-arrested cells. file 2003;22:2274-83.
43. Yannone SM, Roy S, Chan DW, Murphy MB, Huang S, Campisi J, et al. Werner syndrome protein is regulated and phosphorylated by DNA-dependent protein kinase. J Biol Chem 2001;276:38242-8.
44. Kusumoto R, Dawut L, Marchetti C, Wan Lee J, Vindigni A, Ramsden D, et al. Werner protein cooperates with the XRCC4-DNA ligase IV complex in end-processing. Biochemistry 2008;47:7548-56. [Epub 2008 Jun 18].
45. Orren DK, Machwe A, Karmakar P, Piotrowski J, Cooper MP, Bohr VA. A functional interaction of Ku with Werner exonuclease facilitates digestion of damaged DNA. Nucleic Acids Res 2001;29:1926-34.
46. Deutsch E, Dugray A, AbdulKarim B, Marangoni E, Maggiorella L, Vaganay S, et al. BCR-ABL down-regulates the DNA repair protein DNA-PKcs. Blood 2001;97:2084-90.
47. Bentley J, Diggle CP, Harnden P, Knowles MA, Kiltie AE. DNA double strand break repair in human bladder cancer is error prone and involves microhomology-associated end-joining. Nucleic Acids Res 2004;32:5249-59.
48. Deriano L, Merle-Beral H, Guipaud O, Sabatier L, Delic J. Mutagenicity of non-homologous end joining DNA repair in a resistant subset of human chronic lymphocytic leukaemia B cells. Br J Haematol 2006;133:520-5.
49. Sallmyr A, Tomkinson AE, Rassool FV. Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks. Blood 2008;112:1413-23.
50. von Kobbe C, Harrigan JA, Schreiber V, Stiegler P, Piotrowski J, Dawut L, et al. Poly(ADP-ribose) polymerase 1 regulates both the exonuclease and helicase activities of the Werner syndrome protein. Nucleic Acids Res 2004; 32:4003-14. (Pubitemid 39199092)